Solara Active Pharma Sciences Ltd

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2021 we hereby enclose disclosure on Related Party Transactions for the second half year ended March 31 2023